newsfilter
← Latest News
GlobeNewswire·

Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference

MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for